79 results
Page 2 of 4
8-K
EX-1.1
l5d30
22 Apr 21
NeuBase Therapeutics Announces Pricing of $40 Million Public Offering of Common Stock
9:33am
424B5
ldnqh
21 Apr 21
Prospectus supplement for primary offering
4:03pm
8-K
EX-99.1
zm9v7v45qf t9p6
13 Aug 20
NeuBase Therapeutics Reports Financial Results for the Third Fiscal Quarter of 2020
4:11pm
8-K
EX-1.1
mhrydnd
29 Apr 20
NeuBase Therapeutics Announces Pricing of $31,500,000 Public Offering of Common Stock
12:00am
UPLOAD
cybr5
19 Sep 19
Letter from SEC
12:00am
8-K
6omakcsbgrrfjy1drl
12 Jul 19
NeuBase Therapeutics Closes Merger Transaction with Ohr Pharmaceutical
5:23pm
424B3
a11oqn8
6 Jun 19
Prospectus supplement
5:15pm
CORRESP
o06xnndh3lmickrpi
22 May 19
Correspondence with SEC
12:00am
UPLOAD
e0d1h
17 May 19
Letter from SEC
12:00am